Ok ong'ere malong'o gimomiyo ng'ato nyalo bedo gi kansa mar prostate, kata kamano, nitie gik mang'eny moseng'ere manyalo miyo ng'ato obed gi tuwo mar kansa mar prostate.
Moko kuom gigo gin:
1. Higni: Bedo gi tuwo mar kansa mar prostate medore kaka ng'ato medo bedo moti, kendo thoth joma yudo tuwono gin chwo ma hikgi osekalo 65.
2. Weche mag anyuola: Chwo ma nigi tuwo mar kansa mar prostate e anyuola, to moloyo wuoro kata owadgi ma nigi tuwono, nigi hinyruok mang'eny.
3. Dhoudi: Chwo ma Jo-Amerka ma Jo-Afrika nigi hinyruok maduong' mar bedo gi kansa mar prostate moloyo chwo ma Jo-Amerka mamoko.
4. Chiemo: Chiemo moting'o mo mang'eny, to moloyo mo mag le, nyalo miyo ng'ato obed gi tuwo mar kansa mar prostate.
5. Bedo gi del mapek: Bedo gi del mapek kata bedo gi del mapek nyalo miyo ng'ato obed gi kansa mar prostate.
6. Hormones: Testosterone kod hormone mamoko mag chwo mang'eny nyalo miyo ng'ato obed gi kansa mar prostate.
7. Tuwo: Tuwo ma ok rum mar prostate, kaka prostatitis, nyalo miyo ng'ato obed gi tuwo mar kansa mar prostate.
8. Lokruok mar anyuola: Lokruok moko mag anyuola, kaka ma yudore e BRCA1 kod BRCA2, nyalo miyo ng'ato obed gi tuwo mar kansa mar prostate.
Ber ng'eyo ni bedo gi achiel kata mokalo kuomgi ok nyis ni ng'ato biro bedo gi tuwo mar kansa mar prostate, kendo chwo mang'eny ma nigi tuwo mar kansa mar prostate onge gi tuwo mar kansa mar prostate.
E wi mano, nitie nonro matimore mondo ong'e gimomiyo ng'ato nyalo bedo gi kansa mar prostate, kendo mondo ong'e gik mamoko manyalo miyo ng'ato obed gi kansa mar prostate.
Riihimäki M, Thomsen H, Brandt A, Sundquist J, Hemminki K: What do prostate cancer patients die of? Oncologist. 2011, 16 (2): 175-81.
Gilligan T: Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control. 2005, 16 (1): 45-53.
Newschaffer CJ, Otani K, McDonald MK, Penberthy LT: Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 2000, 92 (8): 613-21.
Frydenberg M, Wijesinha S: Diagnosing prostate cancer - what GPs need to know. Aust Fam Physician. 2007, 36 (5): 345-7.
Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.
Martínez-Salamanca JI, Ballesteros CM, Carballido Rodríguez J: [Epidemiological fundamentals of clinically localized prostate cancer]. Arch Esp Urol. 2011, 64 (8): 703-10.
Ng'at ma kwedo weche mag thieth
Websaitni olos mondo okony ji ng'eyo weche mag thieth, to ok mondo okonygi ng'eyo kaka ginyalo tiyo gi yore mag thieth.
Weche mochiw ok onego oti kodgi e fwenyo kata thiedho tuwo moro, kendo jogo madwaro ng'eyo kaka ginyalo thiedho tuwo moro, onego owuo gi laktar molony.
Ng'e ni neural net ma chiwo dwoko mag penjo, ok en makare ahinya sama iwuoyo kuom kwan mag ji, kaka kwan mar joma nigi tuwo moro.
Kinde duto many paro mar laktar kata ng'at machielo molony e weche thieth e wi tuwo moro. Kik iket kiawa kuom paro mar laktar kata duoko chien kwayo mar thieth nikech gimoro ma isomo e websaitni. Kapo ni iparo ni inyalo bedo gi chandruok mar thieth, luong 911 kata dhi e od thieth machiegni mapiyo. Onge tudruok moro amora e kind laktar gi jatuwo ma yudore e websaitni kata e tiyo kode. BioMedLib kata jotichne, kata ng'ato ang'ata ma konyo e websaitni, ok nyal chiwo paro moro amora, kata ma ok ong'ere, e wi weche ma yudore e websaitni kata e tiyo kode.
Ng'eyo ni ng'ato nigi ratiro mar timo gik moko
Digital Millennium Copyright Act mar 1998, 17 U.S.C. § 512 (the DMCA) chiwo yore mag kony ne joma nigi ratiro mag ndiko ma paro ni weche ma yudore e Intanet ketho ratiro ma gin-go kaluwore gi chike mag ndiko mag piny Amerka.
Kapo ni iyie gi adiera ni weche moro amora ma yudore e websait marwa kata e tijewa ketho ratiro ma in-go mar ndiko weche, in (kata ng'at mochung'ne) inyalo oronwa barua ka ikwayo ni ogol weche ma yudore e websaitno, kata mondo ogeng' ng'ato kik yudgi.
Weche ma ng'ato onego owach nyaka oor e yo mondik kokalo kuom e-mail (ne "Contact" e wi adres mar e-mail).
DMCA dwaro ni ng'eyo ma in-go kuom ketho chik mar copyrights oting'o weche maluwogi: (1) ler mar tij copyrights ma ikwano ni oketho; (2) ler mar weche ma ikwano ni oketho chik mar copyrights kod weche moromo mondo okonywa ng'eyo kama wechego nitie; (3) weche mag tudruok kodi, moriwo adresni, namba mar simo kod adres mar email; (4) weche ma in-go manyiso ni in gi yie maber ni weche ma ondik e yo ma ikwedo ok oyie gi jal ma nigi ratiro mar copyrights, kata gi ng'at mochung'ne, kata gi chik moro amora;
(5) weche ma in iwuon iwacho, ma iketo e bwo buch kuong'ruok, ni weche manie kalatasno gin adier, kendo ni in gi teko mar tiyo gi ratiro mag ndiko ma ji wacho ni oketh;
(6) kod signature mar ng'at ma nigi ratiro mar timo gik moko, kata ng'at ma nigi ratiro mar timo gik moko e lo ng'at ma nigi ratiro mar timo gik moko.
Ka ok iketo weche duto monyis malo kae, mano nyalo miyo idonj e kesno bang'e.
Wuo gi ng'at machielo
Ka in gi penjo kata paro moro amora, yie iornwa e-mail.
What causes prostate cancer?
The exact cause of prostate cancer is not known, but several factors have been identified that may increase the risk of developing the disease.
These include:
1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.
2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, are at a higher risk.
3. Race: African American men have a higher risk of developing prostate cancer than men of other races.
4. Diet: A diet high in fat, particularly animal fat, may increase the risk of prostate cancer.
5. Obesity: Being overweight or obese may increase the risk of developing prostate cancer.
6. Hormones: High levels of testosterone and other male hormones may increase the risk of prostate cancer.
7. Inflammation: Chronic inflammation of the prostate, such as prostatitis, may increase the risk of prostate cancer.
8. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of prostate cancer.
It is important to note that having one or more of these risk factors does not mean that a man will definitely develop prostate cancer, and many men with prostate cancer have no known risk factors.
Additionally, research is ongoing to better understand the causes of prostate cancer and identify additional risk factors.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Chiegni ni
BioMedLib tiyo gi kompyuta ma tiyo gi masinde (ma iluongo ni machine-learning algorithms) e loso penjo gi dwoko.
Ne wachako gi buge milion 35 mag weche thieth miluongo ni PubMed/Medline. Bende, ne wachako gi buge mag RefinedWeb.
